Paper - WANFANG MED ONLINE

You Position: Home > Paper

Screening for prevention: promoting the screening of diabetes and its chronic complications

( views:106, downloads:249 )

Author:: No author available

Journal Title:: Chinese Journal of Health Management

Issue:: 2

DOI:: 10.3760/cma.j.issn.1674-0815.2017.02.001

Key Word:: No keyword available

Abstract：随着经济的迅速发展,糖尿病及其并发症的患病率越来越高.中国作为人口大国,糖尿病患病率达到11.6％,糖尿病前期人群更是达到了50.1％[1].2016年,世界糖尿病日的主题是“Eye on Diabetes”,提出2型糖尿病(T2DM)筛查对于改变疾病进程和减少并发症风险非常重要,糖尿病并发症筛查是各类型糖尿病管理的核心内容.糖尿病筛查有助于降低糖尿病发病率及降低糖尿病并发症的风险,糖尿病并发症筛查有助于延缓并发症进展,防止严重并发症发生,特别是致残致死等严重后果,起到“以筛促防”的作用[2].

Reference

[1]黎晓新.学习推广中国糖尿病视网膜病变防治指南，科学规范防治糖尿病视网膜病变[J].2015,(2).
[2]俞丹,向爱华,邓红英,等.HbA1c和空腹血糖在糖尿病筛查中的应用价值[J].2011,(11).
[3]Ma Hui,GAO Xin,LIN Huan Dong,etc.Glycated Haemoglobin in Diagnosis of Diabetes Mellitus and Pre-diabetes among Middle-aged and Elderly Population: Shanghai Changfeng Study[J].2013,(3).
[4]王文宇.尿糖和血糖检验在糖尿病诊断中应用分析[J].2016,(5).
[5]马辰星,许颖,康向辉,等.空腹血糖诊断糖尿病截点的探讨与评价[J].2014,(17).
[6]及长虹.尿糖定性试验和意义[J].2009,(22).
[7]苏伟,王莉,尚有全,等.空腹血浆葡萄糖、口服葡萄糖耐量试验和糖化血红蛋白筛查糖代谢异常的观察[J].2013,(2).
[8]张昕,沈水仙,罗飞宏,等.上海市卢湾区青少年2型糖尿病患病率调查[J].2006,(3).
[9]中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013年版）[J].2014,(7).
[10]光明日报.《中国居民营养与慢性病状况报告（2015年）》发布[J].2015,(13).
[11]朱玲,王蕾蕾,曾平,等.糖尿病筛查量表与糖尿病、糖耐量受损的相关性分析[C].2013.
[12]孙子林,刘乃丰,王基平.运用流动注射分析技术检测血清糖基化终产物-肽水平[J].2000,(4).
[13]李乃适,张念荣,李光伟.生活方式干预是预防2型糖尿病的重要举措[J].2013,(5).
[14]Bing-Quan Yang,YANG Lu,Jia-Jia He,etc.Performance of Fasting Plasma Glucose and Postprandial Urine Glucose in Screening for Diabetes in Chinese High-risk Population[J].2015,(24).
[15]崔焕波.口服葡萄糖耐量试验在糖尿病中的临床价值[J].2013,(12).
[16]包玉倩.糖化血红蛋白临床应用解析[J].2013,(1).
[17]储小宏,丛安丽,吴邦庆,等.HbA1c与OGTT在糖尿病诊断中的应用比较[J].2011,(9).
[18]谢作玲,张林,王艳萍,等.血清糖基化终产物-肽在社区糖尿病高危人群中的筛查价值[J].2012,(40).
[19]杨旭斌,朱延华,陆莹,等.Ewing试验及心率变异性对初诊2型糖尿病患者心血管自主神经病变诊断的比较[J].2012,(6).
[20]彭金娟,邹海东,王伟伟,等.上海市北新泾社区糖尿病视网膜病变远程筛查系统的应用研究[J].2010,(3).
[21]施春晓,徐磊.门诊患者尿常规筛查糖尿病600例结果分析[J].2009,(19).
[22]Yuzhe, Feng,Felix J, Schl?sser,Bauer E, Sumpio.The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy.[J].2009,50(3).
[23]范丽凤,王国红,陶旭,等.1110例口服葡萄糖耐量试验不良反应及影响因素的探讨[J].1994,(7).
[24]Jinjuan, Peng,Haidong, Zou,Weiwei, Wang,etc.Implementation and first-year screening results of an ocular telehealth system for diabetic retinopathy in China.[J].2011,11.
[25]Kate, Haigh,John, Bingley,Jonathan, Golledge,etc.Peripheral arterial disease - screening in general practice.[J].2013,42(6).
[26]Lieverse AG,VAN-Loon LJ,Manders RJ,etc.Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes.[J].2006,38(12).
[27]R. Singh,A. Barden,T. MoriL. Beilin.Advanced glycation end-products: a review[J].2001,44(2).
[28]M, Zendjabil.[The glycated hemoglobin: indication, interpretation and limitations].[J].2015,73(5).
[29]N F, Liu,Z L, Sun,B C, Liu.Clearance of increased serum advanced glycosylation end products in patients with end stage renal disease by hemodialysis.[J].2000,21(3).
[30]Kuo-Liong, Chien.An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes: response to Schulze et al.[J].2007,30.
[31]Weibing, Wang,William P, McGreevey,Chaowei, Fu,etc.Type 2 diabetes mellitus in China: a preventable economic burden.[J].2009,15(9).
[32]Dunky A,Cauza E,Haber P,etc.Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system.[J].2005,35(12).
[33]Chaicharn, Deerochanawong,Alessandra, Ferrario.Diabetes management in Thailand: a literature review of the burden, costs, and outcomes.[J].2013,9.
[34]R.J. Tapp,P.Z. Zimmet,C.A. Harper,etc.Diagnostic thresholds for diabetes: The association of retinopathy and albuminuria with glycaemia[J].2006,73(3).
[35]Alex, Ward,Piedad, Alvarez,Lien, Vo,etc.Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012).[J].2014,17(3).
[36]Bright J,Fitzsimons K,Cooper AR,etc.Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial.[J].2011,378(9786).
[37]W C, Knowler.Screening for NIDDM. Opportunities for detection, treatment, and prevention.[J].1994,17(5).
[38]Einar Stefánsson,Toke Bek,Massimo Porta,etc.Screening and prevention of diabetic blindness[J].2000,78(4).
[39].Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.[J].1998,352(9131).
[40]时霄冰,于生元,杨爱民,等.震动感觉阈值检查对老年糖尿病周围神经病变的诊断价值[J].2013,(18).
[41]Karasik Avraham,Laakso Markku,Hanefeld Markolf,etc.Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.[J].2002,359(9323).
[42]Hanson, Robert L.,Knowler, William C.,Vijayakumar, Pavithra,etc.HbA(1c) and the Prediction of Type 2 Diabetes in Children and Adults[J].2017,40(1).
[43]吴航,孙子林.糖尿病肾病的发病机制和药物干预研究进展[J].2016,(5).
[44]Hu R,Lu B,Zhao N,etc.High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.[J].2010,88(3).
[45]Zilin S,Naifeng L,Bicheng L,etc.The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy.[J].2001,313(1).
[46]Reekers,J.,Schaper,N.C.,Zierler,R.E.,etc.Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011[J].2012,28(Suppl.1).
[47]Olafsdottir, Eydis,Andersson, Dan K. G.,Dedorsson, Inger,etc.Early detection of type 2 diabetes mellitus and screening for retinopathy are associated with reduced prevalence and severity of retinopathy[J].2016,94(3).
[48]Vinik AI,Mehrabyan A.Diagnosis and management of diabetic autonomic neuropathy.[J].2003,29(2).
[49]Michael D. Abramoff,James C. Folk,Dennis P. Han,etc.Automated Analysis of Retinal Images for Detection of Referable Diabetic Retinopathy[J].2013,131(3).
[50]Taillefer R,Engel S,Filipchuk N,etc.Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study.[J].2004,27(8).
[51]Duan X,He J,Reynolds K,etc.Major causes of death among men and women in China.[J].2005,353(11).
[52]Bennett PH,Gong Q,Li H,etc.The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.[J].2008,371(9626).
[53]田杰,任弘,张一民.芬兰、德国、中国版糖尿病风险筛查量表的比较及中国版量表的修订[J].2016,(10).
[54]Knowler WC,Barrett Connor E,Fowler SE,etc.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.[J].2002,346(6).
[55]Bennett PH,Zhang J,Gong Q,etc.Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.[J].2011,54(2).
[56]Mansberger, Steven L.,Sheppler, Christina,Barker, Gordon,etc.Long-term Comparative Effectiveness of Telemedicine in Providing Diabetic Retinopathy Screening Examinations A Randomized Clinical Trial[J].2015,133(5).
[57]Jian-Jun Dong,Neng-jun LOU,Jia-jun ZHAO,etc.Evaluation of a risk factor scoring model in screening for undiagnosed diabetes in China population[J].2011,(10).
[58]K, Rebrin,G M, Steil,W P, van Antwerp,etc.Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring.[J].1999,277(3 Pt 1).
[59]Per Hyltoft, Petersen,Lone G M, J?rgensen,Ivan, Brandslund,etc.Consequences of bias and imprecision in measurements of glucose and hba1c for the diagnosis and prognosis of diabetes mellitus.[J].2005,240.
[60]A, Risso,F, Mercuri,L, Quagliaro,etc.Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture.[J].2001,281(5).
[61]Kose C,Gencalioglu O,Sevik U.Automatic segmentation of age-related macular degeneration in retinal fundus images.[J].2008,38(5).
[62]Rungrawee, Navicharern,Yupin, Aungsuroch,Sureeporn, Thanasilp.Effects of multifaceted nurse-coaching intervention on diabetic complications and satisfaction of persons with type 2 diabetes.[J].2009,92(8).
[63]Irene G M, van Valkengoed,Everlina M A, Vlaar,Vera, Nierkens,etc.The Uptake of Screening for Type 2 Diabetes and Prediabetes by Means of Glycated Hemoglobin versus the Oral Glucose Tolerance Test among 18 to 60-Year-Old People of South Asian Origin: A Comparative Study.[J].2015,10.
[64]Zhaolan, Liu,Chaowei, Fu,Weibing, Wang,etc.Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China.[J].2010,8.
[65]Lee CM,Colagiuri S,Borch Johnsen K,etc.Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes.[J].2011,34(1).
[66]Simon, Barquera,Ismael, Campos-Nonato,Carlos, Aguilar-Salinas,etc.Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy.[J].2013,9.
[67]潘长玉,陆菊明,田慧,等.2型糖尿病患者初诊时血管并发症患病率的调查分析[J].1997,(4).
[68]Metab, Al-Geffari.Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in Primary Health Care setting.[J].2012,6(2).
[69]Khalilzadeh O,Esteghamati A,Anvari M.The economic costs of diabetes: a population-based study in Tehran, Iran.[J].2009,52(8).
[70]Yu, Xu,Limin, Wang,Jiang, He,etc.Prevalence and control of diabetes in Chinese adults.[J].2013,310(9).
[71]Klaus-Dieter Kohnert,Petra Augstein,Peter Heinke,etc.Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes[J].2007,77(3).
[72]Shanhu, Qiu,Xue, Cai,Xiang, Chen,etc.Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials.[J].2014,12.
[73]Tien Yin Wong,Jie Ding.Current epidemiology of diabetic retinopathy and diabetic macular edema.[J].2012,12(4).
[74]Zilin, Sun,Jiajia, He,Shanhu, Qiu,etc.Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects.[J].2015,10(9).
[75]Writing committee,N. Unwin,J. Shaw,etc.Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention[J].2002,19(9).
[76]Chiasson JL,Josse RG,Gomis R,etc.Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.[J].2003,290(4).
[77]Lozano, Rafael,Naghavi, Mohsen,Foreman, Kyle,etc.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.[J].2012,380(9859).
[78]Yau,J.W.Y.,Rogers,S.L.,Kawasaki,R.,etc.Global prevalence and major risk factors of diabetic retinopathy[J].2012,35(3).
[79]雷程灏.空腹血糖联合餐后段间尿糖定量监测在社区糖尿病筛查中的应用评价[D].2011.
[80]Links TP.Back to Basics in Diagnosing Diabetic Polyneuropathy With the Tuning Fork![J].2005,28(9).
[81]Cavan, David.Why screen for type 2 diabetes?[J].2016,121.
[82]Scanlon PH.The English national screening programme for sight-threatening diabetic retinopathy.[J].2008,15(1).
[83]Luo Y,Ji LN,Zhou XH.Performance of HbA(1c) for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing.[J].2009,26(12).
[84]Murray, Christopher J. L.,Vos, Theo,Lozano, Rafael,etc.Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.[J].2012,380(9859).
[85]Criqui MH.Peripheral arterial disease--epidemiological aspects.[J].2001,6(3 Suppl.).
[86]Wang, Yao,Yuan, Yuexing,Zhang, Yanli,etc.Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes[J].2017,54(5).
[87]Lindström, Jaana,Tuomilehto, Jaakko.The Diabetes Risk Score.[J].2003,26(3).
[88]Anglin RE,Panju A,Kanji JN,etc.Does this patient with diabetes have large-fiber peripheral neuropathy?[J].2010,303(15).
[89]Tao T,Hu Y,Wang L,etc.Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.[J].2010,47(3).
[90]Klein BE.Overview of epidemiologic studies of diabetic retinopathy.[J].2007,14(4).
[91]Barr, R. Graham,Nathan, David M.,Meigs, James B.,etc.Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus.[J].2002,137(4).
[92]Carman TL,Azam SM.Diagnostic approach to peripheral arterial disease.[J].2011,29(3).
[93]Zhou X,Pang Z,Gao.Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.[J].2010,33(3).
[94]Qiu, Shanhu,Cai, Xue.Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: A Meta-Analysis.[J].2014,9(10).
[95]M. ABRAHAM,O.A. MOJIMINIYI,K.F. AL-JARALLAH,etc.Back to basics: ankle reflex in the evaluation of peripheral neuropathy in type 2 diabetes mellitus[J].2012,105(4).
[96]Vazeou A.Continuous blood glucose monitoring in diabetes treatment.[J].2011,93(Suppl.1).
[97]Garcia M,Sanchez CI,Poza J.Detection of hard exudates in retinal images using a radial basis function classifier.[J].2009,37(7).
[98]Freeman R,Kempler P,Boulton AJ,etc.Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.[J].2010,33(10).
[99]Chin,E.K.,Ventura,B.V.,See,K.-Y.,etc.Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in Rural and Urban Clinics[J].2014,20(2).
[100]Siu, Albert L..Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: US Preventive Services Task Force Recommendation Statement[J].2015,163(11).
[101]The Eye Diseases Prevalence Research Group.The Prevalence of Diabetic Retinopathy Among Adults in the United States.[J].2004,122(4).
[102]Goldberg, P.,Siegel, M.,Russell, R.,etc.Experience with the Continuous Glucose Monitoring System in a Medical Intensive Care Unit[J].2004,6(3).